Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 12 (RPL5P12) is a processed pseudogene related to the ribosomal protein L5 (RPL5) gene. Unlike the functional RPL5 gene, RPL5P12 does not encode a functional protein, and no biological activity has been attributed to it. Pseudogenes such as RPL5P12 are generally considered non-coding and are not active in protein synthesis or disease pathways. RPL5P12 is a non-functional segment of DNA that is homologous to the ribosomal protein L5 gene but does not produce a protein or perform biological functions. It is not considered a therapeutic target as it does not encode a functional protein and is not reported to be involved in disease mechanisms or drug interactions. It has no known biological function, disease association, or drug interaction profile. The correct entry for an active, disease-relevant target would be its functional parent gene, Ribosomal protein L5 (RPL5).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 12 (RPL5P12).